Protara Therapeutics, Inc.TARANASDAQ
LOADING
|||

Analyst Sentiment

Analysts lean bullish — 100% recommend buying.

Consensus Rating
Buy
5 analysts·Limited coverage
100%
Rating Distribution
Strong Buy
00%
Buy
5100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 70% higher.

Bear Case
$12.00
+70%
Consensus
$12.00
+70%
Bull Case
$12.00
+70%
Price Range5 analysts
Low
Consensus
High
$12.00
$12.00
Current Target
Current Price
$7.04
Upside to Target
$4.96

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Beat rate:75%(9/12 quarters)
Avg surprise:+15.1%
Beat
Miss
Inline
Estimate
Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Apr 16, 2025Scotiabank
Protara Therapeutics initiated with an Outperform at Scotiabank
Target:$12.00
+200.0%from $4.00